These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8035101)

  • 1. The effect of recombinant human erythropoietin on hemostasis, fibrinolysis, and blood rheology in autologous blood donors.
    Biesma DH; Bronkhorst PJ; de Groot PG; van de Wiel A; Kraaijenhagen RJ; Marx JJ
    J Lab Clin Med; 1994 Jul; 124(1):42-7. PubMed ID: 8035101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of recombinant human erythropoietin on hemostatic status in chronic uremic patients.
    Tsao CJ; Kao RH; Cheng TY; Huang CC; Chang SL; Lee FN
    Int J Hematol; 1992 Apr; 55(2):197-203. PubMed ID: 1511168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of recombinant human erythropoietin on hemostasis and fibrinolysis in hemodialysis patients.
    Wirtz JJ; van Esser JW; Hamulyák K; Leunissen KM; van Hooff JP
    Clin Nephrol; 1992 Nov; 38(5):277-82. PubMed ID: 1451341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemostasis during normal pregnancy and puerperium.
    Hellgren M
    Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Variations in hemostasis and fibrinolysis during the treatment of acute myocardial infarct (AMI) with tissue-type plasminogen activator (TTPA). A study of 17 cases].
    Izaguirre Avila R; Ruiz de Chávez Cervantes A; Villavicencio R; Gómez Trigos A; Mar Chavira R; Spíndola Mdel C; Casanova JM
    Arch Inst Cardiol Mex; 1993; 63(3):235-40. PubMed ID: 8347053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of recombinant human erythropoietin (EPOCH) on the coagulation and fibrinolytic systems and platelet function in pre-dialysis patients with chronic renal failure.
    Kaizu K; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):989-97. PubMed ID: 8255011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of recombinant human erythropoietin in the peri-surgical setting.
    Goodnough LT
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():203-10. PubMed ID: 2182736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial.
    Ricci G; Cerneca F; Simeone R; Pozzobon C; Guarnieri S; Sartore A; Pregazzi R; Guaschino S
    Hum Reprod; 2004 Apr; 19(4):838-48. PubMed ID: 15016779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of recombinant human erythropoietin on hematological and hemostatic parameters with special reference to microhemolysis.
    Maurin N; Fitzner S; Fritz H; Gladziwa U; H agel J; Stefanidis I
    Clin Nephrol; 1995 Mar; 43(3):196-200. PubMed ID: 7774078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemorheological, coagulative and fibrinolytic changes during autologous blood donation.
    Clivillé X; Bofill C; Joven J; Monasterio J; Viscor G; Vernis M; Angles A; Sans T
    Clin Hemorheol Microcirc; 1998 Jul; 18(4):265-72. PubMed ID: 9741667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Improvement of hemorheologic parameters in hemodialyzed patients treated with human recombinant erythropoietin].
    Delamaire M; Durand F; Hamel D; Joyeux V; Lepogamp P; Genetet B
    J Mal Vasc; 1991; 16(3):289-94. PubMed ID: 1940657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
    Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
    Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of patient size and dose of recombinant human erythropoietin therapy on red blood cell volume expansion in autologous blood donors for elective orthopedic operation.
    Goodnough LT; Verbrugge D; Marcus RE; Goldberg V
    J Am Coll Surg; 1994 Aug; 179(2):171-6. PubMed ID: 8044386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antiretroviral therapy on hemostasis in Brazilian pregnant women with HIV infection.
    de Andrade CM; Duarte G; Quintana SM; Montes MB; Toloi MR
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):769-74. PubMed ID: 17982318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors.
    LeBlanc R; Roy J; Demers C; Vu L; Cantin G
    Bone Marrow Transplant; 1999 May; 23(10):991-6. PubMed ID: 10373063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of platelet functions, some hemostatic and fibrinolytic parameters in relation to serotonin in hemodialyzed patients under erythropoietin therapy.
    Malyszko J; Malyszko JS; Borawski J; Rydzewski A; Kalinowski M; Azzadin A; Mysliwiec M; Buczko W
    Thromb Res; 1995 Jan; 77(2):133-43. PubMed ID: 7740505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced platelet reactivity with erythropoietin but not following transfusion in dialysis patients.
    Roger SD; Piper J; Tucker B; Raine AE; Baker LR; Kovacs IB
    Nephrol Dial Transplant; 1993; 8(3):213-7. PubMed ID: 8385286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.